The Drug Screening Market size is estimated to grow from USD 5.5 Billion in 2020 to USD 17.1 Billion by 2027, growing at a CAGR of 19.2% during the forecast year from 2021 to 2027.
The Drug Screening Market research report thoroughly explains each and every aspect related to the Global Drug Screening Market, which facilitates the report’s reader to study and evaluate the upcoming market trend and execute the analytical data to promote the business.
A large-scale Drug Screening Market document offers an all-inclusive study about production capacity, consumption, import, and export for all the major regions across the world. Furthermore, the statistical and numerical data such as facts and figures are represented very neatly in the report by using charts, tables, or graphs. This market report also involves strategic profiling of the major players in the market, comprehensive analysis of their basic competencies, and thereby keeping the competitive landscape of the market in front of the client. The winning Drug Screening report covers all the market shares and approaches of the major competitors or the key players in the market.
Request for Sample Copy of This Report @ https://marketdigits.com/drug-screening-market/sample/
Scroll down 100s of data Tables, charts and graphs spread through Pages and in-depth Table of Content on “Drug Screening Market, By Product (Equipment, Rapid Testing Devices, Consumables, Laboratory Services), Sample Type (Breath Sample, Urine Sample, Hair Sample, Oral Fluid Sample), End-User & Geography – Global Forecast To 2027”. Early buyers will get 10% customization on study.
To Avail deep insights of Drug Screening Market Size, competition landscape is provided i.e. Revenue Analysis (M $US) by Company (2018-2020), Segment Revenue Market Share (%) by Players (2018-2020) and further a qualitative analysis is made towards market concentration rate, product/service differences, new entrants and the technological trends in future.
Unlock new opportunities in Drug Screening Market; the latest release from MarketDigits highlights the key market trends significant to the growth prospects, Let us know if any specific players or list of players needs to consider to gain better insights.
Purchase Full Report @ https://marketdigits.com/drug-screening-market/buy/
The drug screening market size is estimated to grow from USD 5.5 Billion in 2020 to USD 17.1 Billion by 2027, growing at a CAGR of 19.2% during the forecast year from 2021 to 2027. Growth in this market is attributed to the rising drug & alcohol consumption, the enforcement of stringent laws mandating drug and alcohol testing, government funding in major markets, and regulatory approvals and product and service launches. On the other hand, bans on alcohol consumption in Islamic countries and the prohibition of drug testing at workplaces in certain regions are some major factors that may hinder the market growth
COVID-19 impact on the drug screening market
COVID-19 has resulted in significant disruptions to businesses and economic activities globally and is expected to have a short-term negative impact on the drug screening market due to limited or non-availability of medical facilities/treatment centers, harm reduction service providers, and the fear of infection transmission. To reduce the strain on the healthcare system and decrease disease transmission, various governments worldwide provided guidelines to postpone or delay non-essential medical and surgical procedures. Restrictions and lockdowns were also imposed in travel, business operations, public gatherings, and shelter-in-place orders, all of which have further impacted market growth. Several countries across the globe announcing nationwide lockdowns and the temporary closures of industries, manufacturing, production, and business development have been severely affected. Trade barriers have further negatively impacted the demand-supply gap. Companies operating in the drug screening market have witnessed disruptions in the global supply chain, reduced demand, or suspension of operations by their customers.
Global Drug screening Market Dynamics
DRIVER: Growing drug and alcohol consumption
Drug abuse and alcohol consumption are increasing across the globe. According to the World Drug Report 2019, in 2017, about 5.5% of the global population aged 15–64 consumed drugs at least once. In 2017, 35 million people had substance use disorders, a 14.8% increase from 30.5 million in 2016. In the same year, 585,000 people died as a result of drug use. The extent of harm caused by drugs is equal to losing 28 million years of “healthy” life (disability-adjusted life years or DALYs) globally. Alcohol consumption has shown similar increases, with consequences witnessed in the rising incidence of impaired driving. To curb the menace of drug and alcohol abuse, authorities in various countries are focusing on implementing comprehensive drug and alcohol testing measures. Thus, the demand for drug and alcohol testing is expected to increase in the coming years.
RESTRAINT: prohibition on workplace drug testing in some countries
Some countries, such as Canada, Colombia, Argentina, Chile, and South Africa, consider drug and alcohol testing at the workplace to be a violation of employee privacy. For instance, in France, pre-employment drug testing is only performed when physicians recommend the test. In Poland and the Czech Republic, drug and alcohol tests in the workplace are prohibited. In Canada, the Eastern Canadian case laws permit drug and alcohol testing only when workplace operations are inherently dangerous or where drug and alcohol testing is limited to a few special cases. This may hinder the adoption of drug and alcohol testing in these markets.
OPPORTUNITY: Emerging economies
Fingerprint-based drug testing is a relatively new concept that has gained ground due to the COVID-19 pandemic. The coronavirus has made it difficult to carry out drug testing in hospitals, labs, and other facilities because of the risk of transmitting the infection. Here, fingerprint-based drug screening can help limit the spread of COVID; it is non-invasive, less time-consuming, hygienic, enables social distancing, portable, user-friendly, and requires no specific preparation for sample collection and handling. This test is very easy to implement whenever and wherever required, thus offering flexible and effective workplace drug testing. The test analyzes small traces of sweat in the fingerprint to detect drug and drug metabolites. If this test is widely adopted, it is expected to replace urine, hair, and blood-based drug tests. This is a significant opportunity for the market players to capitalize on in the drug screening market.
The rapid testing devices segment will witness the highest growth during the forecast period.
Based on product, the drug screening market is segmented into analytical instruments, rapid testing devices, and consumables. Rapid testing devices market is further subsegmented into urine testing devices and oral fluid testing devices. The urine testing devices segment is expected to account for the largest market share in 2019. However, the oral fluid testing devices segment is projected to register highest CAGR during the forecast period. The high growth in this segment is attributed to the benefits it offers such as shorter detection window, non-invasive nature, and low risk of sample tampering.
The urine sample segment dominated the drug screening market in 2019.
The global drug screening market by sample type is segmented into urine, breath, oral fluid, hair, and other samples. The urine sample segment is estimated to account for the largest share in 2019; however, the oral fluid samples segment is expected to register the highest growth rate during the forecast period.
The workplace end-user segment accounted for the largest share of the drug screening market in 2019 and is also expected to grow at the highest CAGR during the forecast period.
Based on end-users, the drug screening market is segmented into workplaces, criminal justice systems & law enforcement, drug treatment centers, pain management centers, schools & colleges, hospitals, individual users, and drug testing laboratories. In 2019, the workplace testing segment is expected to account for the largest share of the market. The growth of this end-user segment can be attributed to the growing safety concerns in the workplace and the increasing number of organizations that have made regular drug screening mandatory.
North America was the largest regional market for drug screening market in 2019.
The drug screening market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America was the largest regional segment of the overall market, followed by Europe. The dominance of the North American market is attributed to factors such as rising consumption of illicit drugs, availability of government funding to curb drug abuse, and the presence of laws supporting drug screening, and growing burden of accidents due to unsafe levels of alcohol consumption.
Key Market Players
The prominent players operating in this market include LabCorp (US), Quest Diagnostics (US), Alere (US), OraSure (US), Alfa Scientific Designs (US), Thermo Fisher Scientific (US), Drägerwerk (Germany), LifeLoc (US), MPD Inc. (US), Omega Laboratories (US), Premier Biotech (US), Psychemedics (US), Roche (Switzerland), Shimadzu (Japan), and Siemens Healthineers (Germany).
By Product and Service
- Drug Screening Products
- Analytical Instruments
- Immunoassay Analyzers
- Chromatography Instruments
- Fuel-cell Breathalyzers
- Semiconductor Breathalyzers
- Other Breathalyzers
- Rapid Testing Devices
- Urine Testing Devices
- Drug Testing Cups
- Dip Cards
- Drug Testing Cassettes
- Oral Fluid Testing Devices
- Urine Testing Devices
- Assay Kits
- Sample Collection Tubes
- Calibrators & Controls
- Other Consumables
- Analytical Instruments
- Drug Screening Services
By Sample Type
- Urine Samples
- Oral Fluid Samples
- Breath Samples
- Hair Samples
- Other Samples
By End User
- Drug Testing Laboratories
- Criminal Justice Systems & Law Enforcement Agencies
- Drug Treatment Centers
- Individual Users
- Pain Management Centers
- Schools & Colleges
- North America
- Asia Pacific
- Rest of the World
- In 2020, LabCorp Entered into a multi-year agreement with Infirmary Health (US) to offer laboratory testg services in the eastern Gulf Coast.
- In 2020, Psychemedics introduced a vaping panel test that detects the ingestion of marijuana, CBD, and nicotine drugs by all methods, including electronic cigarettes or smoking
- In 2019, Quest Diagnostics acquired some assets of the clinical laboratory services business of Boston Clinical Laboratories. This allowed BCL’s patients and providers to access Quest services.
- In 2017, Alfa Scientific Designs introduced a new product line, Instant-view-PLUS.
What Porter’s Five Forces of Competitive Analysis Provides?
Competitive rivalry:- The main driver is the number and capability of competitors in the market. Many competitors, offering undifferentiated products and services, will reduce market attractiveness.
Threat of substitution:- Where close substitute products exist in a market, it increases the likelihood of customers switching to alternatives in response to price increases. This reduces both the power of suppliers and the attractiveness of the market.
Threat of new entry:- Profitable markets attract new entrants, which erodes profitability. Unless incumbents have strong and durable barriers to entry, for example, patents, economies of scale, capital requirements or government policies, then profitability will decline to a competitive rate.
Supplier power:- An assessment of how easy it is for suppliers to drive up prices. This is driven by the: number of suppliers of each essential input; uniqueness of their product or service; relative size and strength of the supplier; and cost of switching from one supplier to another.
Buyer power:- An assessment of how easy it is for buyers to drive prices down. This is driven by the: number of buyers in the market; importance of each individual buyer to the organisation; and cost to the buyer of switching from one supplier to another. If a business has just a few powerful buyers, they are often able to dictate terms.
Five forces analysis helps organizations to understand the factors affecting profitability in a specific industry, and can help to inform decisions relating to: whether to enter a specific industry; whether to increase capacity in a specific industry; and developing competitive strategies.
The country section of the report also provides individual market impacting factors & changes in regulation in the market domestically that impacts the current & future trends of the market. Data points such as consumption volumes, production sites & volumes, import export analysis, price trend analysis, cost of raw materials, down-stream & upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence & availability of global brands & their challenges faced due to large or scarce competition from local & domestic brands, impact of domestic tariffs & trade routes are considered while providing forecast analysis of the country data.
Any Questions? Inquire Here Before Buying @ https://marketdigits.com/drug-screening-market/analyst/
MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.
We offer services that are most relevant and beneficial to the users, which help businesses to sustain in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.
USA : +1 847 450 0808
Email : firstname.lastname@example.org